Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Plegridy Observational Program

ClinicalTrials.gov ID: NCT02230969

Public ClinicalTrials.gov record NCT02230969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program

Study identification

NCT ID
NCT02230969
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Biogen
Industry
Enrollment
1,208 participants

Conditions and interventions

Interventions

  • peginterferon beta-1a Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2014
Primary completion
Jan 19, 2022
Completion
Jan 19, 2022
Last update posted
Sep 25, 2022

2014 – 2022

United States locations

U.S. sites
50
U.S. states
33
U.S. cities
47
Facility City State ZIP Site status
Research Site Homewood Alabama 35209
Research Site Gilbert Arizona 85234
Research Site Scottsdale Arizona 85258
Research Site Berkeley California 94705
Research Site California City California 93449
Research Site Hanford California 93230
Research Site Orange California 92868
Research Site Basalt Colorado 81621
Research Site Colorado Springs Colorado 80907
Research Site Washington D.C. District of Columbia 20007
Research Site Washington D.C. District of Columbia 20037
Research Site Delray Beach Florida 33445
Research Site Atlanta Georgia 30327
Research Site Schaumburg Illinois 60173
Research Site Indianapolis Indiana 46256
Research Site Des Moines Iowa 50314
Research Site Iowa City Iowa 52242
Research Site Louisville Kentucky 40207
Research Site New Orleans Louisiana 70121
Research Site Scarborough Maine 04074
Research Site Boston Massachusetts 02215
Research Site Lexington Massachusetts 02421
Research Site Worcester Massachusetts 01655
Research Site Southfield Michigan 48034
Research Site Golden Valley Minnesota 55422
Research Site St Louis Missouri 63131
Research Site Great Falls Montana 59405
Research Site Lebanon New Hampshire 03756
Research Site Freehold New Jersey 07728
Research Site Albuquerque New Mexico 87131
Research Site Buffalo New York 14203
Research Site New Hyde Park New York 11042
Research Site New York New York 10016
Research Site Staten Island New York 10306
Research Site Charlotte North Carolina 28203
Research Site Hickory North Carolina 28602
Research Site Raleigh North Carolina 27607
Research Site Dayton Ohio 45417
Research Site Dayton Ohio 45459
Research Site Oklahoma City Oklahoma 73104
Research Site Oklahoma City Oklahoma 73112
Research Site Portland Oregon 97225
Research Site Pittsburgh Pennsylvania 15212
Research Site Port Royal South Carolina 29935
Research Site Knoxville Tennessee 37934
Research Site Bedford Texas 76021
Research Site Salt Lake City Utah 84103
Research Site Richmond Virginia 23298
Research Site Virginia Beach Virginia 23456
Research Site Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02230969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02230969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →